Viatris Inc (VTRS)
Viatris Inc. operates as a global pharmaceutical and healthcare enterprise. Its business is structured across four primary geographic divisions: Developed Markets, Greater China, JANZ (Japan, Australia, New Zealand), and Emerging Markets. The company offers a comprehensive range of pharmaceutical products, encompassing branded prescription medications, generic and complex generic drugs, biosimilar treatments, and active pharmaceutical ingredients (APIs). These offerings target diverse therapeutic areas, addressing both noncommunicable and infectious diseases. Its biosimilars specifically focus on critical conditions in oncology, immunology, endocrinology, ophthalmology, and dermatology. Furthermore, Viatris's APIs are utilized across numerous drug categories, including antibacterials, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitors. Beyond manufacturing medicines, Viatris supports patient well-being through additional services such as diagnostic clinics, educational seminars, and digital tools designed to assist with health management. Products are made available in various forms, including oral solids, injectable solutions, complex dosage formulations, and raw APIs. Viatris distributes these to a broad clientele globally, including retail pharmacies, wholesalers, government bodies, insurance providers, and institutional healthcare facilities. The distribution network involves pharmaceutical wholesalers, retail and institutional pharmacies, mail-order and e-commerce platforms, and specialty pharmacies. The company's extensive portfolio includes prominent brands like Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, Yupelri, Norvasc, Viagra, AMITIZA, Lipacreon, Effexor, Celebrex, and ARV. Its biosimilar franchises feature products such as Fulphila, Ogivri, Hulio, and SEMGLEE. Viatris Inc. also fosters innovation through strategic collaborations and licensing agreements with partners including Revance Therapeutics, Inc., Momenta Pharmaceuticals, Inc., Theravance Biopharma, Inc., Biocon Ltd., and Fujifilm Kyowa Kirin Biologics Co. Ltd. Founded in 1961, Viatris Inc. maintains its corporate headquarters in Canonsburg, Pennsylvania.
Sector: Pharmaceutical Preparations
Industry: Drug Manufacturers - Specialty & Generic
Viatris Inc.
NASDAQ:VTRSHealthcare · Drug Manufacturers - Specialty & Generic
-0.86%$19.04
AH$18.91-0.66%vs close
Mkt Cap$21.86B
Float1.15B
O/S1.15B
Vol
$ Vol
RVOL
Inst Own91.5%
SI3.3%
Earnings
Div Yield2.52%
Dilution
Financials Summary
Revenue$14.3B
Net Income-$3.51B
Total Assets$37.19B
Free Cash Flow$1.94B
Debt & Equity
Debt 50%
Equity 50%
Total Debt$14.7B
Total Equity$14.71B
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in VTRS's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$37.19B
Liabilities$22.48B
Accounts Receivable$3.35B
Accounts Payable$1.29B
Inventory$4B
PP&E (Net)$2.89B
Goodwill$6.75B
Intangible Assets$15.1B
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2005 | FY 2004 | FY 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-30 | 2017-12-30 | 2016-12-30 | 2015-12-30 | 2014-12-30 | 2013-12-30 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-03-31 | 2005-03-31 | 2004-03-31 |
| Revenue | $14.3B | $14.74B | $15.43B | $16.26B | $17.89B | $11.95B | $11.5B | $11.43B | $11.91B | $11.08B | $9.43B | $7.72B | $6.91B | $6.8B | $6.13B | $5.45B | $5.09B | $5.14B | $2.91B | $1.26B | $1.25B | $1.37B |
| YoY Growth | -3.0% | -4.5% | -5.1% | -9.1% | 49.7% | 3.9% | 0.6% | -4.0% | 7.5% | 17.5% | 22.1% | 11.7% | 1.7% | 10.9% | 12.5% | 7.0% | -0.9% | 76.9% | 131.1% | 0.3% | -8.8% | - |
| Cost of Revenue | $9.29B | $9.12B | $8.99B | $9.77B | $12.31B | $8.15B | $7.6B | $7.43B | $7.12B | $6.38B | $5.21B | $4.19B | $3.87B | $3.89B | $3.57B | $3.23B | $3.02B | $3.07B | $1.74B | $629.55M | $629.83M | $612.15M |
| Gross Profit | $5.01B | $5.62B | $6.44B | $6.5B | $5.58B | $3.8B | $3.9B | $4B | $4.78B | $4.7B | $4.22B | $3.53B | $3.04B | $2.91B | $2.56B | $2.22B | $2.07B | $2.07B | $1.17B | $627.62M | $623.54M | $762.47M |
| Gross Margin | 35.1% | 38.2% | 41.7% | 40.0% | 31.2% | 31.8% | 33.9% | 35.0% | 40.2% | 42.4% | 44.7% | 45.7% | 44.0% | 42.8% | 41.8% | 40.7% | 40.7% | 40.3% | 40.1% | 49.9% | 49.7% | 55.5% |
| Research and Development | $965.9M | $808.7M | $805.2M | $662.2M | $681M | $512.6M | $639.9M | $704.5M | $783.3M | $826.8M | $671.9M | $581.8M | $507.8M | $401.3M | $294.73M | $282.15M | $275.26M | $317.22M | $194.75M | $102.43M | $88.25M | $100.81M |
| Selling, General, and Administrative | $3.79B | $4.43B | $4.65B | $4.18B | $4.53B | $3.34B | $2.56B | $2.44B | $2.58B | $2.5B | $2.18B | $1.63B | $1.41B | $1.39B | $1.21B | $1.09B | $1.05B | $1.05B | $599.46M | $225.38M | $259.11M | $201.61M |
| Other | $2.92B | $379.2M | $217.1M | $40.8M | $399.3M | $150.3M | -$21.4M | -$49.5M | -$13.1M | $672.5M | -$97.4M | -$32.1M | -$11.5M | $5.2M | $48.56M | $127.06M | $225.72M | $401.63M | $0 | $12.42M | -$25.99M | -$34.76M |
| Total Operating Expenses | $7.68B | $5.61B | $5.67B | $4.88B | $5.61B | $4.01B | $3.18B | $3.1B | $3.35B | $4B | $2.76B | $2.18B | $1.9B | $1.8B | $1.56B | $1.5B | $1.55B | $1.77B | $794.21M | $340.23M | $321.37M | $267.67M |
| Operating Income (EBIT) | -$2.66B | $10.1M | $766.2M | $1.61B | -$34M | -$210.8M | $715.5M | $905.6M | $1.44B | $699.2M | $1.46B | $1.35B | $1.14B | $1.11B | $1.01B | $721.58M | $523.35M | $297.88M | $371.72M | $287.39M | $302.17M | $494.8M |
| Operating Margin | -18.6% | 0.1% | 5.0% | 9.9% | -0.2% | -1.8% | 6.2% | 7.9% | 12.1% | 6.3% | 15.5% | 17.5% | 16.4% | 16.3% | 16.4% | 13.2% | 10.3% | 5.8% | 12.8% | 22.9% | 24.1% | 36.0% |
| Interest Expense | $471.3M | $550M | $573.1M | $592.4M | $636.2M | $497.8M | $517.3M | $542.3M | $534.6M | $454.8M | $336.4M | $333.2M | $313.3M | $319M | $333.1M | $277.96M | $266.75M | $380.78M | $239.21M | $31.29M | $0 | $0 |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $12.3M | $0 | $0 | $0 | $0 | $0 | $0 | $6.7M | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$1B | -$633.3M | -$563.3M | $1.2B | -$630.4M | -$510.4M | -$561.1M | -$607.2M | -$534.2M | -$577.5M | -$545.5M | -$378.1M | -$388.2M | -$305.2M | -$350.81M | -$365.64M | -$296.38M | -$345.71M | -$1.81B | -$12.78M | $10.08M | $17.81M |
| Income Before Tax (EBT) | -$3.67B | -$623.2M | $202.9M | $2.81B | -$664.4M | -$721.2M | $154.4M | $298.4M | $903M | $121.7M | $915.4M | $974.5M | $747.3M | $804.08M | $654.64M | $355.94M | $226.97M | -$71.56M | -$1.44B | $274.61M | $312.25M | $512.61M |
| Income Tax Expense | -$150.1M | $11M | $148.2M | $734.6M | $604.7M | -$51.3M | $137.6M | -$54.1M | $207M | -$358.3M | $67.7M | $41.4M | $120.8M | $161.15M | $115.83M | $10.4M | -$20.77M | $128.55M | $80.1M | $90.06M | $108.66M | $178M |
| Net Income | -$3.51B | -$634.2M | $54.7M | $2.08B | -$1.27B | -$669.9M | $16.8M | $352.5M | $696M | $480M | $847.6M | $929.4M | $623.7M | $640.85M | $536.81M | $345.12M | $232.57M | -$196.08M | -$1.52B | $184.54M | $203.59M | $334.61M |
| Net Income Margin | -24.6% | -4.3% | 0.4% | 12.8% | -7.1% | -5.6% | 0.1% | 3.1% | 5.8% | 4.3% | 9.0% | 12.0% | 9.0% | 9.4% | 8.8% | 6.3% | 4.6% | -3.8% | -52.2% | 14.7% | 16.2% | 24.3% |
| Supplementary Data | ||||||||||||||||||||||
| EPS | -3.00 | -0.53 | 0.05 | 1.71 | -1.05 | -1.11 | 0.03 | 0.69 | 1.30 | 0.94 | 1.80 | 2.49 | 1.63 | 1.54 | 1.25 | 0.69 | 0.31 | -0.64 | -5.90 | 0.80 | 0.76 | 1.24 |
| Diluted EPS | -3.00 | -0.53 | 0.05 | 1.71 | -1.05 | -1.11 | 0.03 | 0.68 | 1.30 | 0.92 | 1.70 | 2.34 | 1.58 | 1.52 | 1.22 | 0.68 | 0.30 | -0.64 | -5.90 | 0.79 | 0.74 | 1.21 |
| Weighted Average OS | 1.17B | 1.19B | 1.20B | 1.21B | 1.21B | 601.20M | 516.50M | 516.50M | 535.38M | 520.50M | 497.40M | 397.18M | 394.50M | 415.21M | 430.84M | 324.45M | 305.16M | 304.36M | 257.15M | 229.39M | 268.99M | 268.93M |
| EBITDA | -$395.4M | $2.64B | $3.52B | $6.43B | $4.48B | $1.99B | $2.69B | $2.95B | $3.24B | $2.1B | $2.29B | $1.87B | $1.58B | $1.66B | $1.5B | $1.11B | $946.63M | $734.5M | -$991.8M | $334.21M | $347.27M | $539.12M |
| EBITDA Margin | -2.8% | 17.9% | 22.8% | 39.6% | 25.0% | 16.7% | 23.4% | 25.8% | 27.2% | 19.0% | 24.3% | 24.3% | 22.8% | 24.4% | 24.5% | 20.4% | 18.6% | 14.3% | -34.1% | 26.6% | 27.7% | 39.2% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2005 | FY 2004 | FY 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-30 | 2017-12-30 | 2016-12-30 | 2015-12-30 | 2014-12-30 | 2013-12-30 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-03-31 | 2005-03-31 | 2004-03-31 |
| Assets | ||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||
| Cash and Cash Equivalents | $1.35B | $734.8M | $991.9M | $1.26B | $701.2M | $844.4M | $475.6M | $388.1M | $292.1M | $998.8M | $1.24B | $225.5M | $291.3M | $349.97M | $384.33M | $686.02M | $428.48M | $597.46M | $484.2M | $150.12M | $137.73M | $111.48M |
| Short-Term Investments | $106.4M | $355.1M | $192.5M | $212.6M | $233.8M | $203.5M | $109.1M | $57.5M | $110.6M | $83.8M | $54M | $28.2M | $27M | $0 | $30.69M | $29.09M | $27.56M | $42.26M | $91.36M | $368M | $670.35M | $585.45M |
| Cash and Short-Term Investments | $1.45B | $1.09B | $1.18B | $1.47B | $935M | $1.05B | $584.7M | $449.2M | $418.9M | $1.14B | $1.35B | $284.1M | $408.6M | $349.97M | $415.02M | $715.11M | $456.04M | $639.72M | $575.56M | $518.13M | $808.08M | $696.93M |
| Accounts Receivable | $3.35B | $3.52B | $4.04B | $4.14B | $4.27B | $4.84B | $3.06B | $2.42B | $3.17B | $3.02B | $2.43B | $2.27B | $1.82B | $1.55B | $1.43B | $1.16B | $1.23B | $1.16B | $1.13B | $242.19M | $297.33M | $191.09M |
| Inventory | $4B | $3.85B | $3.47B | $3.52B | $3.98B | $5.47B | $2.67B | $2.58B | $2.54B | $2.46B | $1.95B | $1.65B | $1.66B | $1.53B | $1.4B | $1.24B | $1.11B | $1.07B | $1.06B | $279.01M | $286.27M | $320.8M |
| Other Current Assets | $194.8M | $913.8M | $4.13B | $1.31B | $1.47B | $1.24B | $286.2M | $791.2M | $958.8M | $743.2M | $601.3M | $0 | $386M | $229.35M | $202.9M | $282.7M | $296.88M | $239.59M | $192.11M | $137.67M | $119.33M | $78.48M |
| Total Current Assets | $9.22B | $9.52B | $12.98B | $10.64B | $10.9B | $12.87B | $6.76B | $6.37B | $7.21B | $7.52B | $6.47B | $6.44B | $4.47B | $3.9B | $3.57B | $3.56B | $3.29B | $3.17B | $3.06B | $1.19B | $1.53B | $1.33B |
| Long-Term Assets | ||||||||||||||||||||||
| Property, Plant & Equipment Net | $2.89B | $2.92B | $3.01B | $3.28B | $3.48B | $3.78B | $2.4B | $2.17B | $2.34B | $2.32B | $1.98B | $1.79B | $1.67B | $1.4B | $1.3B | $1.21B | $1.12B | $1.06B | $1.1B | $406.88M | $336.72M | $273.05M |
| Goodwill | $6.75B | $9.13B | $9.87B | $10.43B | $12.11B | $12.35B | $9.59B | $9.75B | $10.21B | $9.23B | $5.38B | $4.05B | $4.34B | $3.52B | $3.52B | $3.6B | $3.33B | $3.16B | $3.86B | $102.58M | $102.58M | $0 |
| Intangible Assets | $15.1B | $17.07B | $19.18B | $22.61B | $26.13B | $29.68B | $11.65B | $13.66B | $15.25B | $14.45B | $7.22B | $2.35B | $2.52B | $2.22B | $2.63B | $2.5B | $2.38B | $2.45B | $2.98B | $105.59M | $120.49M | $237.18M |
| Long-Term Investments | $815M | $1.35B | $1.14B | $1.09B | $81.4M | $47.9M | $92.2M | $138.7M | $226M | $396.4M | $475.5M | $547.4M | $494.8M | $0 | $0 | $0 | $0 | $0 | $0 | $462K | $0 | $0 |
| Deferred Tax Assets | $1.06B | $753M | $692.9M | $925.9M | $1.33B | $2.15B | $703.1M | $572.2M | $496.8M | $633.2M | $457.6M | $83.4M | $77.83M | $87.66M | $39.38M | $58.28M | $36.61M | $16.49M | $18.7M | $0 | $0 | $0 |
| Other Long-Term Assets | $1.35B | $754M | $821.1M | $1.05B | $798.5M | $676M | $58.2M | $73.7M | $79.6M | $172.2M | $276M | $566.4M | $1.73B | $804.2M | $543.21M | $609.25M | $641M | $523.46M | $337.56M | $63.12M | $47.43M | $47.22M |
| Total Long-Term Assets | $27.97B | $31.98B | $34.71B | $39.39B | $43.94B | $48.69B | $24.5B | $26.37B | $28.59B | $27.2B | $15.79B | $9.38B | $10.82B | $8.03B | $8.03B | $7.98B | $7.52B | $7.22B | $8.29B | $678.63M | $607.22M | $557.45M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $37.19B | $41.5B | $47.69B | $50.02B | $54.84B | $61.55B | $31.26B | $32.73B | $35.81B | $34.73B | $22.27B | $15.82B | $15.29B | $11.93B | $11.6B | $11.54B | $10.8B | $10.39B | $11.35B | $1.87B | $2.14B | $1.89B |
| Liabilities | ||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||
| Accounts Payable | $1.29B | $1.36B | $1.38B | $1.16B | $1.06B | $1.35B | $1.06B | $1.24B | $1.45B | $1.35B | $1.11B | $905.6M | $1.07B | $777.91M | $703.24M | $564.71M | $518.25M | $498.81M | $643.87M | $76.86M | $78.11M | $50.41M |
| Short-Term Debt | $2.04B | $600K | $1.93B | $1.25B | $3.35B | $3.41B | $1.46B | $657.1M | $1.8B | $269.7M | $1B | $2.78B | $455.6M | $397.04M | $817.2M | $167.26M | $190.7M | $154.49M | $549.73M | $4.34M | $1.59M | $1.59M |
| Current Income Tax Payable | $0 | $192.7M | $226.8M | $279.6M | $236.9M | $288.6M | $213M | $121.5M | $112.9M | $97.7M | $92.4M | $160.9M | $50.54M | $35.01M | $44.09M | $17.56M | $71.11M | $94.09M | $133.72M | $12.96M | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.22B | $1.51B | $1.98B | $1.2B | $1.01B | $784.2M | $301.66M | $265.55M | $203.52M | $259.85M | $275.41M | $133.72M | $37.29M | $0 | $0 |
| Other Current Liabilities | $2.88B | $1.34B | $1.41B | $1.24B | $1.41B | $2.22B | $832.8M | $2.29B | $2.62B | $2.92B | $1.55B | $604.1M | $651.4M | $320.62M | $777.17M | $874.13M | $749.34M | $615.94M | $541.32M | $146.77M | $92.78M | $82.72M |
| Total Current Liabilities | $7.09B | $5.78B | $7.78B | $6.75B | $9.88B | $10.56B | $5.57B | $4.59B | $6.39B | $5.04B | $4.12B | $5.3B | $2.96B | $2.19B | $2.56B | $1.81B | $1.72B | $1.54B | $2B | $265.25M | $245.51M | $183.54M |
| Long-Term Liabilities | ||||||||||||||||||||||
| Long-Term Debt | $12.48B | $14.04B | $16.19B | $18.02B | $19.72B | $22.43B | $11.21B | $13.16B | $12.87B | $15.2B | $6.3B | $5.7B | $7.59B | $5.34B | $4.48B | $5.26B | $4.98B | $5.08B | $4.71B | $685.19M | $19.32M | $19.13M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$1.72B | -$2.01B | -$2.01B | -$718.1M | -$235.4M | -$468.53M | $0 | $0 | $0 | $0 | $18.02M | $122.87M | $89.42M | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $892M | $1.11B | $1.74B | $2.43B | $2.81B | $3.12B | $1.63B | $1.72B | $2.01B | $2.01B | $718.1M | $235.4M | $468.53M | $274.26M | $308.92M | $478.09M | $467.5M | $577.38M | $876.82M | $20.59M | $24.91M | $22.6M |
| Other Long-Term Liabilities | $1.84B | $1.76B | $1.35B | $1.58B | $1.73B | $2.25B | $785.1M | $1.1B | $1.24B | $1.36B | $1.37B | $1.54B | $1.78B | $0 | $742.21M | $370.32M | $485.9M | $387.54M | $206.67M | $22.43M | $0 | $0 |
| Total Long-Term Liabilities | $15.39B | $17.09B | $19.44B | $22.2B | $24.47B | $28.04B | $13.8B | $15.98B | $16.11B | $18.57B | $8.38B | $7.24B | $9.37B | $6.38B | $5.53B | $6.11B | $5.94B | $6.06B | $5.91B | $817.63M | $44.23M | $41.73M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $22.48B | $22.87B | $27.22B | $28.95B | $34.35B | $38.6B | $19.37B | $20.57B | $22.5B | $23.61B | $12.5B | $12.54B | $12.33B | $8.58B | $8.09B | $7.92B | $7.66B | $7.61B | $7.92B | $1.08B | $289.74M | $225.27M |
| Stockholders' Equity | ||||||||||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.07M | $1.07M | $1.07M | $0 | $0 | $0 |
| Common Stock | $12.5M | $12.3M | $12.2M | $12.1M | $12.1M | $12.1M | $6.1M | $6M | $6M | $6M | $5.5M | $273.3M | $272M | $269.83M | $265.16M | $262.91M | $198.34M | $197.68M | $197.63M | $154.57M | $152.22M | $151.78M |
| Retained Earnings | -$388.3M | $3.42B | $4.64B | $5.18B | $3.69B | $5.36B | $6.03B | $6.01B | $5.64B | $4.94B | $4.46B | $3.61B | $2.69B | $2.06B | $1.42B | $883.71M | $660.13M | $566.59M | $922.86M | $1.94B | $1.81B | $1.64B |
| Comprehensive Income & Other | -$2.71B | -$3.21B | -$2.75B | -$2.76B | -$1.74B | -$858M | -$1.8B | -$1.44B | -$361.2M | -$2.26B | -$1.76B | -$987M | -$240.1M | -$86.5M | -$87.84M | $171.87M | $11.81M | -$844.65M | $2.2B | $2.45M | $870K | $2.5M |
| Other Stockholders' Equity | $15.09B | $15.2B | $15.82B | $15.88B | $16.79B | $17.58B | $5.85B | $6.15B | $7.66B | $6.17B | $5.3B | -$631.9M | -$15.3M | $1.01B | $1.81B | $2.46B | $2.27B | $1.99B | $2.28B | -$1.31B | -$115.08M | -$129.49M |
| Total Equity | $14.71B | $18.64B | $20.47B | $21.07B | $20.49B | $22.95B | $11.88B | $12.17B | $13.31B | $11.12B | $9.76B | $3.26B | $2.94B | $3.34B | $3.49B | $3.6B | $3.13B | $2.76B | $3.4B | $787.65M | $1.85B | $1.66B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.4M | $1.4M | $20.1M | $18.1M | $15.11M | $13.01M | $13.52M | $14.05M | $29.11M | $34.33M | $0 | $0 | $0 |
| Total Liabilities and Equity | $37.19B | $41.5B | $47.69B | $50.02B | $54.84B | $61.55B | $31.26B | $32.73B | $35.81B | $34.72B | $22.27B | $15.8B | $15.28B | $11.92B | $11.59B | $11.52B | $10.79B | $10.36B | $11.32B | $1.87B | $2.14B | $1.89B |
| Supplementary Data | ||||||||||||||||||||||
| Total Debt | $14.7B | $14.31B | $18.37B | $19.53B | $23.36B | $26.16B | $12.92B | $13.82B | $14.66B | $15.47B | $7.31B | $8.48B | $8.04B | $5.73B | $5.3B | $5.43B | $5.18B | $5.23B | $5.26B | $689.52M | $20.91M | $20.72M |
| Net Debt | $13.35B | $13.57B | $17.38B | $18.27B | $22.66B | $25.32B | $12.45B | $13.43B | $14.37B | $14.47B | $6.07B | $8.26B | $7.75B | $5.38B | $4.91B | $4.74B | $4.75B | $4.64B | $4.77B | $539.4M | -$116.82M | -$90.77M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2005 | FY 2004 | FY 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-30 | 2017-12-30 | 2016-12-30 | 2015-12-30 | 2014-12-30 | 2013-12-30 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-03-31 | 2005-03-31 | 2004-03-31 |
| Operating Activities | ||||||||||||||||||||||
| Net Income | -$3.51B | -$634.2M | $54.7M | $2.08B | -$1.27B | -$669.9M | $16.8M | $352.5M | $696M | $480M | $847.6M | $929.4M | $623.7M | $640.85M | $536.81M | $345.12M | $232.57M | -$196.08M | -$1.52B | $184.54M | $203.59M | $334.61M |
| Depreciation & Amortization | $2.8B | $2.71B | $2.74B | $3.03B | $4.51B | $2.22B | $2.02B | $2.11B | $1.81B | $1.52B | $1.03B | $566.6M | $516M | $546.6M | $510.69M | $422.79M | $401.16M | $425.28M | $210.4M | $46.83M | $45.1M | $44.32M |
| Deferred Income Tax | -$476.5M | -$767.6M | -$387.1M | -$25.9M | $675.7M | -$213.2M | -$192.6M | -$264.3M | -$111.4M | -$609.5M | -$115.9M | -$315.2M | -$87.13M | -$108.93M | -$57.41M | $11.29M | -$154.65M | -$193.56M | -$77.13M | -$23.64M | -$36.9M | $32.27M |
| Stock-Based Compensation | $177.7M | $146.1M | $180.7M | $116.4M | $111.2M | $79.2M | $56.8M | -$70.6M | $74.7M | $88.9M | $92.8M | $66M | $47M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Changes in Working Capital: | ||||||||||||||||||||||
| Accounts Receivable | $334.6M | $300.1M | $78.6M | -$240.3M | $59.3M | $78.7M | -$20M | $340.1M | -$162.2M | -$131.8M | $65.8M | -$231.2M | -$553.5M | -$354.84M | -$318.87M | $21.86M | -$175.8M | -$172.45M | -$124.39M | $19.08M | -$192.8M | $18.62M |
| Inventory | -$106.4M | -$723.4M | -$613.3M | -$259.5M | -$427.6M | -$741.9M | -$512.9M | -$547.6M | -$129.5M | -$279.3M | -$320.4M | -$147.5M | -$157.1M | -$172.02M | -$220.6M | -$94.73M | $20.11M | -$83.33M | $16.3M | $6.01M | $34.53M | -$83.02M |
| Accounts Payable | -$168M | $36M | $314.7M | $170.2M | -$70.4M | -$82.7M | -$96.3M | $220.3M | $14.4M | $87.7M | $131.8M | -$300K | $137.21M | $81.43M | $133.67M | $23.02M | $4.24M | $23.17M | $86.47M | $20.53M | $8.08M | -$25.38M |
| Other Working Capital | -$2.56B | $68.7M | -$491.3M | -$593M | -$1.37B | $49.6M | $121.4M | -$177.9M | -$420.3M | -$523.6M | -$44.2M | -$173.1M | $85.8M | -$227.12M | -$64.47M | -$92.6M | -$113.01M | $41.16M | -$30.18M | $68.82M | $6M | -$24.16M |
| Total Working Capital Change | -$2.5B | -$318.6M | -$711.3M | -$922.6M | -$1.8B | -$696.3M | -$507.8M | -$385.4M | -$712M | -$934.7M | -$298.8M | -$551.8M | -$624.8M | -$672.55M | -$470.27M | -$142.44M | -$264.45M | -$191.44M | -$51.79M | $114.44M | -$144.18M | -$113.94M |
| Other Non-Cash Items | $5.84B | $1.17B | $922.1M | -$1.28B | $797.4M | $515.9M | $411.2M | $599.6M | $311.7M | $1.5B | $450.7M | $319.8M | $631.83M | $543.05M | $200.6M | $294.65M | $390.45M | $540.25M | $1.6B | $94.38M | $136.1M | -$71.69M |
| Net Cash from Operating | $2.32B | $2.3B | $2.8B | $3B | $3.02B | $1.23B | $1.8B | $2.34B | $2.06B | $2.05B | $2.01B | $1.01B | $1.11B | $949.02M | $720.42M | $931.4M | $605.08M | $384.45M | $167.69M | $416.56M | $203.71M | $225.58M |
| Investing Activities | ||||||||||||||||||||||
| Capital Expenditures | -$378.8M | -$326M | -$377M | -$489.4M | -$509.4M | -$681.2M | -$406M | -$252.1M | -$275.9M | -$390.4M | -$362.9M | -$325.3M | -$334.6M | -$305.32M | -$279.85M | -$192.79M | -$154.4M | -$165.11M | -$110.54M | -$103.69M | -$90.75M | -$118.45M |
| Acquisitions | $0 | -$350M | -$667.7M | $0 | $277M | $415.8M | -$148.7M | -$65.9M | -$167M | -$6.79B | -$693.1M | -$50M | -$1.26B | $16.34M | -$80.51M | -$557.82M | -$187.44M | $0 | -$7B | $0 | $0 | $12M |
| Purchases of Investments | -$23.9M | -$26M | -$26.3M | -$30.2M | -$30.2M | -$104.8M | -$25.8M | -$63.4M | -$96.5M | -$30.2M | -$62.1M | -$19.9M | -$19.35M | -$9.88M | -$10.02M | -$7.52M | $0 | -$18.03M | -$275.8M | -$686.57M | -$780.81M | -$793.54M |
| Sales of Investments | $23.9M | $26M | $26.3M | $29.9M | $29.8M | $47M | $27.1M | $85.2M | $96.6M | $21.5M | $33.1M | $20.2M | $10.6M | $8.06M | $0 | $4.57M | $15.72M | $65.71M | $357.92M | $991.06M | $693.29M | $647.78M |
| Other Investing Activities | -$48.9M | $2.48B | $280.6M | $1.96B | $115M | $22.1M | $28M | -$892.4M | -$533.5M | -$497.5M | -$513.7M | -$425M | -$272.3M | -$80.4M | $23.31M | $3.28M | -$1.42M | -$35.4M | -$4.98M | -$5.71M | $3.37M | $1.88M |
| Net Cash from Investing | -$427.7M | $1.8B | -$764.1M | $1.47B | -$117.8M | -$301.1M | -$525.4M | -$1.21B | -$976.4M | -$7.68B | -$1.57B | -$800.3M | -$1.87B | -$371.21M | -$347.07M | -$750.28M | -$327.54M | -$152.83M | -$7.04B | $195.09M | -$174.89M | -$250.33M |
| Financing Activities | ||||||||||||||||||||||
| Debt Repaid | $100K | $3.71B | $1.25B | $1.79B | $2.49B | $1.5B | $1.1B | $587.3M | $1.36B | -$5.46B | -$1.03B | $60.8M | -$1.49B | -$44.96M | $186.2M | -$241.23M | $343.58M | -$56.82M | -$3.31B | -$687.94M | - | -$9.77M |
| Common Stock Issuance | $2.6M | $2.5M | $3.1M | $3.3M | $0 | $600K | $0 | $0 | $0 | $13.8M | $0 | $53.8M | $0 | $0 | $0 | $54.65M | $19.62M | $48.68M | $2.74B | $56.89M | $10.07M | $26.67M |
| Common Stock Repurchases | -$500.5M | -$250M | -$250M | $0 | -$17.4M | $0 | $0 | -$432M | -$500.2M | -$17.5M | -$67.5M | -$27.7M | -$1B | -$999.9M | -$350M | $0 | $0 | $0 | $0 | -$1.26B | $0 | -$133.09M |
| Dividends Paid | -$561.2M | -$574.8M | -$575.6M | -$581.6M | -$399M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$139.03M | $0 | $0 | -$13.83M | -$49.77M | -$32.26M | -$26.02M |
| Other Financing Activities | -$234.9M | $205.6M | -$229.8M | -$19.5M | -$496.5M | -$205M | -$66.1M | -$27.2M | -$33.4M | -$152.1M | $7.4M | -$98.8M | $57.1M | $17.61M | -$160.92M | $25.57M | $0 | -$161.17M | $20.18M | -$21.79M | $19.62M | -$9.77M |
| Net Cash from Financing | -$1.29B | -$4.33B | -$2.3B | -$3.88B | -$3.01B | -$605.7M | -$1.17B | -$1.09B | -$1.89B | $5.34B | $604.8M | -$267.4M | $692.9M | -$611.52M | -$645M | $100.35M | -$454.43M | -$166.94M | $6.07B | -$599.26M | -$2.57M | -$132.44M |
| Forex Effect | $17.6M | -$30.7M | -$2.5M | -$38.9M | -$30.9M | $33.8M | -$7.5M | -$21M | $27.6M | -$9.6M | -$33.1M | -$12.9M | $10.6M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $611.9M | -$257.5M | -$268.9M | $556.3M | -$143.8M | $358.9M | $101.8M | $19.4M | -$777.1M | -$89M | $1.01B | -$65.8M | -$58.67M | -$34.36M | -$301.69M | $257.54M | -$168.97M | $113.25M | $334.08M | $12.39M | $36.02M | -$157.19M |
| Supplementary Data | ||||||||||||||||||||||
| Operating Cash Flow | $2.32B | $2.3B | $2.8B | $3B | $3.02B | $1.23B | $1.8B | $2.34B | $2.06B | $2.05B | $2.01B | $1.01B | $1.11B | $949.02M | $720.42M | $931.4M | $605.08M | $384.45M | $167.69M | $416.56M | $203.71M | $225.58M |
| Capital Expenditure | -$378.8M | -$326M | -$474.5M | -$489.4M | -$509.4M | -$681.2M | -$406M | -$252.1M | -$275.9M | -$390.4M | -$362.9M | -$325.3M | -$334.6M | -$305.32M | -$279.85M | -$192.79M | -$154.4M | -$165.11M | -$110.54M | -$103.69M | -$90.75M | -$118.45M |
| Free Cash Flow | $1.94B | $1.98B | $2.33B | $2.51B | $2.51B | $550.6M | $1.4B | $2.09B | $1.79B | $1.66B | $1.65B | $689.5M | $772M | $643.69M | $440.58M | $738.61M | $450.67M | $219.33M | $57.15M | $312.87M | $112.97M | $107.13M |
| Cash at Beginning | $736.1M | $993.6M | $1.26B | $706.2M | $850M | $491.1M | $389.3M | $369.9M | $1.15B | $1.24B | $225.5M | $291.3M | $349.97M | $384.33M | $686.02M | $428.48M | $597.46M | $484.2M | $150.12M | $137.73M | $101.71M | $258.9M |
| Cash at End | $1.35B | $736.1M | $993.6M | $1.26B | $706.2M | $850M | $491.1M | $389.3M | $369.9M | $1.15B | $1.24B | $225.5M | $291.3M | $349.97M | $384.33M | $686.02M | $428.48M | $597.46M | $484.2M | $150.12M | $137.73M | $101.71M |